Anesth Analg 1992; 75:932-939
© 1992 International Anesthesia Research Society
Intramuscularly Administered Dexmedetomidine Attenuates Hemodynamic and Stress Hormone Responses to Gynecologic Laparoscopy
M. Aho, MD, M.,
Scheini n, MD, PhD,
A. M. Lehtinen, MD, PhD,
O. Erkola, MD, PhD,
J. Vuorinen, MSc, and
K. Korttila, MD, PhD
Department of Anesthesia, Women's Hospital, University of Helsinki, Helsinki; Department of Pharmacology, University of Turku, Turku; and Orion Corporation, Farmos Research Center, Turku, Finland
Abstract
The hemodynamic and endocrine effects of three different doses of dexmedetomidine (0.6, 1.2, and 2.4 /µg/kg), oxycodone (0.13 mg/kg), and saline solution, injected intramuscularly 45–60 min before induction of general anesthesia, were compared in a double-blind, randomized study involving 100 women undergoing gynecologic diagnostic laparoscopy. Anesthesia was induced with thiopental (4.5 mg/kg) and maintained with 0.3% end-tidal iso-flurane and 70% nitrous oxide in oxygen. Arterial blood pressure and heart rate increased after endotracheal intubation and during laparoscopy in all groups, but the maximal mean arterial pressure after tracheal intubation was lower in the dexmedetomidine 2.4-µg/kg group (104 mm Hg [SD 19]) than in the saline solution group (130 mm Hg [SD 12]). Dexmedetomidine (2.4-and 1.2 µg/kg) attenuated the maximal heart rate after intubation (84 [SD 11] and 101 beats/min [SD 15], respectively) compared with saline solution (116 beats/min [SD 19]). On the other hand, 40% of the patients in the dexmedetomidine 2.4-µg/kg group received atropine in the postanesthesia care unit for bradycardia (heart rate 40 beats/ min). Preoperative anxiety and sedation before and after preanesthetic medication were evaluated by the patients with the aid of a profile of mood-state questionnaire; only dexmedetomidine 2.4 (µg/kg produced significant anxiolysis and sedation. Plasma concentrations of norepinephrine, epinephrine, 3,4-dihydroxyphenylglycol, Cortisol, and /ß-endorphin increased less in the dexmedetomidine 2.4-/µg/kg group in response to tracheal intubation and surgery than in the saline solution group.
This article has been cited by other articles:

|
 |

|
 |
 
V. M. Yuen, M. G. Irwin, T. W. Hui, M. K. Yuen, and L. H. Y. Lee
A Double-Blind, Crossover Assessment of the Sedative and Analgesic Effects of Intranasal Dexmedetomidine
Anesth. Analg.,
August 1, 2007;
105(2):
374 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Mukhtar, E. M. Obayah, and A. M. Hassona
The use of dexmedetomidine in pediatric cardiac surgery.
Anesth. Analg.,
July 1, 2006;
103(1):
52 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Martin, G. Ramsay, J. Mantz, and S. T. J. Sum-Ping
The Role of the {alpha}2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care Unit
J Intensive Care Med,
January 1, 2003;
18(1):
29 - 41.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Venn, A. Bryant, G. M. Hall, and R. M. Grounds
Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit
Br. J. Anaesth.,
May 1, 2001;
86(5):
650 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. O. Talke, D. L. Traber, C. A. Richardson, D. D. Harper, and L. D. Traber
The Effect of {alpha}2 Agonist-Induced Sedation and Its Reversal with an {alpha}2 Antagonist on Organ Blood Flow in Sheep
Anesth. Analg.,
May 1, 2000;
90(5):
1060 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Talke, R. Chen, B. Thomas, A. Aggarwall, A. Gottlieb, P. Thorborg, S. Heard, A. Cheung, S. L. Son, and A. Kallio
The Hemodynamic and Adrenergic Effects of Perioperative Dexmedetomidine Infusion after Vascular Surgery
Anesth. Analg.,
April 1, 2000;
90(4):
834 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Joris, J.-D. Chiche, J.-L. M. Canivet, N. J. Jacquet, J. J. Y. Legros, and M. L. Lamy
Hemodynamic changes induced by laparoscopy and their endocrine correlates: effects of clonidine
J. Am. Coll. Cardiol.,
November 1, 1998;
32(5):
1389 - 1396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Schmeling and N. E. Farber
The Effects of {alpha}2-Adrenergic Agonists on the Cardiovascular System
Seminars in Cardiothoracic and Vascular Anesthesia,
July 1, 1997;
1(2):
178 - 196.
[PDF]
|
 |
|
|